Future Prospects of Global Laboratory Proficiency Testing Market

Image
Laboratory Proficiency Testing Market  The global Laboratory Proficiency Testing Market is estimated to be valued at US$ 1.29 billion in 2023 and is expected to exhibit a CAGR of 7.3% over the forecast period 2023 - 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Laboratory proficiency testing involves evaluating the performance of laboratories for a given scope of testing through inter-laboratory comparisons. It helps assess the quality and competence of laboratories by determining reproducibility and accuracy of test results. Proficiency testing products are used by laboratories to determine method validity and accuracy, and improve testing processes. Market Key Trends: One of the major trends in the laboratory proficiency testing market is the growing number of accredited medical laboratories. Accreditation assures compliance with ISO 15189 and ISO/IEC 17025 standards, which require participation in proficiency testing programs. Accordi

Global Brachytherapy Market Overview and Trends

Brachytherapy is a type of radiotherapy that is used to treat cancers of all types. Internal radiation, or seed therapy, is another name for it. Unlike external beam radiotherapy, which distributes radiation from the outside, brachytherapy precisely targets the dangerous tumour from the inside. Radioactive seeds are implanted into malignant tissue and positioned in such a way that they will most effectively destroy the tumour. The use of brachytherapy to target malignant cells decreases the danger of harm to healthy tissues and organs surrounding the tumour, as well as the possibility of adverse effects. Brachytherapy is used to treat malignancies of the prostate, cervix, breast, and skin, as well as tumours in other parts of the body such the head and neck. Furthermore, it is frequently used in conjunction with chemotherapy medications to reduce the chance of cancer recurrence. Permanent and temporary brachytherapy are the two types of brachytherapy.

The brachytherapy industry is primarily driven by the rising incidence of prostate cancer occurrences. According to the American Cancer Society, around 161,370 people in the United States were diagnosed with prostate cancer in 2017, with approximately 26,730 deaths related to prostate cancer. In the United States, prostate cancer is the third greatest cause of death among males. The expanding acceptance of high dose rate brachytherapy and the rising prevalence of obesity are two key reasons driving the brachytherapy industry forward. However, radiation therapy side effects such as hair loss, fatigue, appetite loss, and nausea are likely to stifle the brachytherapy market's expansion.


https://www.coherentmarketinsights.com/
Brachytherapy Market


Between 2015 and 2020, the global brachytherapy market grew at a moderate rate. Brachytherapy, also known as internal radiation therapy, is a type of radiotherapy in which radiation is delivered directly to a cancerous tumour in the body via a source placed close or next to it. The source emits gamma rays that target cancer cells while minimising damage to healthy tissue nearby. Small radioactive seeds are permanently implanted in or around the tumour in LDR, whereas radioactive sources are removed from the patient's body at the end of each session in HDR, which is employed in the event of high-risk tumours.

 

Comments

Popular posts from this blog

Global Disposable Face Mask Market Share

Future Prospects of Global Laboratory Proficiency Testing Market

Global Ophthalmoscopes Market Overview and Impact of Coronavirus (Covid-19) Pandemic